Lab POL Guide - 2021 - 9

Readers

BD Veritor™ Plus
System

This fast and accurate solution streamlines
the point-of-care (POC) diagnostic
workflow and allows providers to quickly
review patient results and determine the
appropriate treatment in a single
consultation. The system can help detect
infectious diseases such as influenza A and B,
respiratory syncytial virus (RSV), and group A strep
while the patient is still on site, which can enable faster
decision-making for an earlier intervention opportunity.
* Faster access to test results: Help inform appropriate and targeted
treatment decisions
* Improved workflow: Improves workflow with an Analyze Now or Walk
Away mode, providing test results (with a print-enabled function) and
aiding in decision-making while the patient is on site
* Improved traceability: The BD Veritor™ InfoScan module can scan 3
different identifiers (operator ID, specimen ID, and test kit/lot) that can
be locally recorded, printed, or downloaded, and reduces hands-on time
through automated documentation
* Modularity: Provides a unique solution to meet each testing site's
preference
* Connectivity: BD Veritor™ InfoSync module provides the same benefits
as BD Veritor™ InfoScan. Connects and documents tests results across
multiple sites and can integrate with a hospital electronic medical record
or laboratory information system
* Advanced particle technology: Enhances sensitivity by using a proprietary
process to produce highly stable, modified colloidal metal particles
* Adaptive read technology: Compensates for background. Nonspecific
binding helps improve specificity to reduce false-positive results
#256066
(126-5527)........................................................... ea

BD Veritor™ System Flu A+B Test Kit
The first CLIA-waived flu A+B test referenced against PCR, a higher
sensitivity standard than culture.
* Positive percent agreement (A/B): 82.1%/74.6
* Negative percent agreement (A/B): 98.6%/99.6%
* Positive agreement vs. PCR for current visual read rapid tests ranges
from 10% to 70%
* Streamlined workflow: Provides a digital result in 11 minutes, with 50
seconds of hands-on time
#256045, Flu A+B Test Kit
(992-0002)....................................................30/box
CPT® Codes: Influenza A: 87804QW† / Influenza B: 87804-59†; Using
the Objective and Differentiated Reader System: 87999†

DIGIVAL™

Accurately reads and
interprets lateral flow tests
n just seconds, delivering
automated, objective results in any
health-care setting. It is a camera-based
instrument that will detect the presence of, and
identify a completed lateral flow assay, analyze
the intensity of the test and control line, and
display the results (positive, negative, or invalid)
on the color touch-screen.
* Small footprint
* 4.3 " color touch-screen
* Barcode scanner and optional printer
* QC lockout features
* Workflow flexibility
* ReadNOW or Walkaway capabilities
* Data storage: 1000 patient test results
* 100 QC test results
* 50 calibration check test results
* Accurate, objective, rapid results
* Bidirectional connectivity
#LFR-124, DIGIVAL
(132-8754)........................................................... ea
#MCP1810395, Thermal Printer
(131-0547)........................................................... ea
#575000, BinaxNow™ Influenza A&B Card 2
(131-0546).................................................... 22/box
21MS6125

Sofia® Influenza A+B FIA Test

This CLIA-waived test uses advanced
immunofluorescence-based lateral-flow technology
to detect influenza A and B viral nucleoprotein
antigens in nasal and nasopharyngeal swab and
nasopharyngeal aspirate/wash specimens taken
directly from symptomatic patients.
* Enhanced assay sensitivity
* Results in 15 minutes
* Accurate detection with nasal swab, NP swab
and NPA/wash samples
Acucy™ System
* Nasal swab sensitivity (A/B): 90%/89%;
The Acucy™ Influenza A&B Test on the Acucy™
specificity (A/B): 95%/96%
System provides clinicians flexibility in workflow
* NP swab sensitivity (A/B): 97%/90%; specificity
and accurate, standardized results for improved
(A/B): 95%/97%
patient care.
* NPA/wash sensitivity (A/B): 99%/88%; specificity
* CLIA waived
(A/B): 96%/96%
* " Read Now " or " Walk Away " modes
* Room temperature storage
* Results within 15 minutes
* 21-month shelf life from date of manufacture
* Nasal and nasopharyngeal swab types
* For use with Sofia Analyzer (sold separately)
* Includes 2 additional tests for quality-control
* CLIA-waived for nasal and nasopharyngeal
testing
swabs
#1039, Acucy Reader System
#20299, Sofia 2 Analyzer
(136-8725)........................................................... ea (128-5292)........................................................... ea
#1010, Acucy Influenza A&B Test Kit
#20218, Sofia Influenza A+B Test
(136-8722)........................................................... ea (122-4092).................................................... 25/box
CPT® Code: Influenza A: 87804QW†, Influenza B: 87804-59†

9

CPT® Codes: Influenza A: 87804QW†; Influenza B: 87804-59†

henryschein.com/medical
Lab POL Guide - 2021

Table of Contents for the Digital Edition of Lab POL Guide - 2021
